Vitalogy Health and Integrative Medicine: A 2026 Due-Diligence Review
Introduction: Why This Is a Verification Brief, Not a Directory Listing
This article is an independent, third-party due-diligence review of Vitalogy Health and Integrative Medicine, a Denver-based wellness practice. It is not a sponsored profile, a directory listing, or a promotional piece. TopDoctor Magazine has no business, advertising, or editorial affiliation with Vitalogy Health and Integrative Medicine. The clinic is examined here as a neutral case study within TopDoctor Magazine’s broader consumer health and wellness coverage.
Most existing coverage of the practice comes from Yelp, Birdeye, Groupon, and aggregator directories. These sources republish name, address, and phone data alongside star ratings. They rarely explain why those ratings diverge so sharply, and none address the regulatory context now surrounding compounded GLP-1 weight-loss treatments.
This review closes three specific gaps:
- Reconciling the rating spread, which ranges from 3.1 to 4.8 depending on the platform.
- Contextualizing compounded semaglutide and tirzepatide offerings against FDA actions in 2025 and 2026.
- Clarifying “integrative medicine” branding in a nurse practitioner-led practice versus the federal definition used by the National Center for Complementary and Integrative Health (NCCIH).
The piece serves two types of readers: prospective patients vetting the clinic before booking, and researchers comparing platforms before spending money on GLP-1, hormone, or med-spa packages.
Vitalogy Health and Integrative Medicine: The Baseline Facts
- Location: Cherry Creek North neighborhood, 90 Madison St #101, Denver, CO 80206.
- Leadership: The practice is led by Alison Brown, identified in marketing materials and third-party directories as a board-certified nurse practitioner.
- Core service lines:
- Medical weight loss, including semaglutide and tirzepatide
- Hormone replacement therapy, including bioidentical hormones and pellets
- Aesthetic procedures: Botox, CoolSculpting, microneedling, dermaplaning, and laser hair removal
- Lab-based diagnostics
- Positioning: The clinic describes itself as combining “modern medicine with a whole body approach,” focusing on root-cause treatment of hormone imbalance, sexual wellness, vitamin and mineral deficiencies, skin health, and weight concerns. Third-party directories frame it as a “single practice model” that houses weight management, hormone optimization, and dermatologic procedures together, reducing the need to coordinate care across multiple providers.
The clinic’s own blog also draws a distinction between “integrative” and “holistic” medicine. That distinction is revisited later in this review against the federal NCCIH definition.
Reconciling the Rating Discrepancy: 3.1 to 4.8 Across Platforms
The raw numbers, side by side:
| Platform | Average Rating | Sample Size |
|---|---|---|
| Yelp | 3.1 / 5 | 11 reviews |
| Birdeye | 4.4 / 5 | 62 reviews |
| Groupon | 4.4 / 5 | Reported counts vary (figures up to 244 ratings; roughly 22 written reviews) |
| Google (via third-party aggregator) | 4.8 / 5 | 48 reviews |
Why Sample Size Matters
Small-sample platforms are inherently volatile. With only 11 reviews on Yelp, two or three one-star entries can pull the average down by a full point or more. Larger samples, like those on Birdeye and Groupon, tend to dampen the effect of any individual outlier. A 3.1 on 11 reviews and a 4.4 on 62 reviews are not directly comparable data points.
Why Platform Mechanics Matter
Each platform collects and displays reviews differently:
- Yelp uses a recommendation algorithm that filters some reviews out of the visible average, which can disproportionately affect businesses with low review volume.
- Groupon reviews come from deal redeemers, a population that may skew toward first-time, price-sensitive customers evaluating a single discounted service.
- Birdeye frequently reflects reviews solicited by the business after a visit, which can tilt toward satisfied patients who respond to follow-up requests.
- Google ratings, particularly when reported secondhand through an aggregator, may reflect a different timeframe or patient mix.
These structural differences can produce rating discrepancies independent of actual service quality. Readers should avoid anchoring on any single score and instead read the content and recurring themes of reviews across multiple platforms.
What the Reviews Actually Say: Reading Past the Star Rating
Positive Themes
Favorable testimonials cite specific outcomes. One patient reports losing more than 45 pounds during a ten-week weight-loss program. Others describe relief from menopausal symptoms through hormone pellet therapy.
Negative Themes
Critical reviews cluster around two issues:
- Short-notice appointment cancellations, mentioned by more than one reviewer.
- One detailed 2025 complaint alleging that compounded tirzepatide purchased at the clinic was expired or ineffective.
The Attribution Problem
Many testimonials, both on the clinic’s own materials and across directories, use first-name-only or age-only attribution. This is common in healthcare marketing, partly for privacy reasons, but it makes independent verification impossible. Researchers should treat outcome claims such as a specific amount of weight lost as anecdotal rather than as evidence of typical results.
The expired-tirzepatide complaint, in particular, cannot be evaluated fairly without understanding the regulatory backdrop around compounded GLP-1 medications.
The 2025–2026 FDA Crackdown on Compounded GLP-1s: What Changed and Why It Matters
Shortage Resolutions End the Compounding Exception
For much of the GLP-1 boom, compounding pharmacies were permitted to produce copies of semaglutide and tirzepatide because the brand-name drugs were on the FDA’s official shortage list. That changed when the FDA resolved the tirzepatide shortage in December 2024 and the semaglutide shortage in February 2025, as reported by Pharmacy Times. Once the shortages were resolved, the legal basis for mass compounding of these drugs disappeared along with them.
The April 30, 2026 Proposed Rule
On April 30, 2026, the FDA proposed permanently excluding semaglutide, tirzepatide, and liraglutide from the 503B bulk drug substances list, according to the Federal Register notice and Medscape coverage. If finalized, the rule would further restrict outsourcing facilities from compounding these medications going forward.
The March 3, 2026 Enforcement Action
Earlier, on March 3, 2026, the FDA announced warning letters to 30 telehealth companies over false or misleading marketing of compounded GLP-1 products. This action demonstrates that regulatory scrutiny targets the compounded weight-loss injectable market broadly, not any single clinic.
What This Means for Consumers
Compounded GLP-1 products made during or after the shortage-resolution period carry elevated regulatory and quality-control uncertainty compared to FDA-approved, manufacturer-produced semaglutide and tirzepatide. Compounded drugs do not undergo FDA premarket review for safety, efficacy, or manufacturing quality in the way approved products do.
Connecting the Dots: The 2025 Expired-Tirzepatide Complaint in Regulatory Context
The 2025 complaint alleges that compounded tirzepatide purchased at Vitalogy was expired or did not work. Notably, the reviewer explicitly referenced the FDA’s compounding crackdown in describing the experience.
This complaint should be read against an industry-wide pattern. As the shortage justification ended, compounding pharmacies and the clinics sourcing from them faced tightening supply chains and increased oversight. Those conditions can correlate with inventory disruptions, sourcing changes, or quality issues at individual outlets nationwide.
This context neither confirms nor disputes the merits of the specific complaint. TopDoctor Magazine has not independently verified the reviewer’s claims. What the regulatory framework provides is a fair lens: the complaint is neither an isolated service gripe to be dismissed nor proof of misconduct unique to this practice.
Any reader evaluating a clinic offering compounded semaglutide or tirzepatide in 2026 should ask directly:
- Is the product FDA-approved brand-name medication or pharmacy-compounded?
- If compounded, which licensed 503A pharmacy or 503B outsourcing facility produced it?
- What is the lot number and beyond-use date on the vial?
Integrative Medicine: Branding Term vs. Clinical Definition
The Federal Baseline
The NCCIH, part of the National Institutes of Health, defines integrative health as bringing conventional and complementary approaches together in a coordinated way. Academic literature on the terminology emphasizes multimodal interventions and treating the whole person. The National Cancer Institute similarly describes integrative medicine as combining conventional care with complementary practices that science has shown to be safe and effective.
How the Term Is Used in Wellness Branding
In NP-led wellness and med-spa settings, “integrative medicine” often signals a bundle of services under one roof: weight loss, hormone therapy, and aesthetics. This differs from the academic model typically associated with hospital-based integrative medicine centers, which are often physician-staffed and embedded in larger health systems.
Vitalogy’s own blog states that integrative medicine “prioritizes the use of the best available treatments from both conventional and complementary systems.” That is a reasonable articulation, but it remains brand messaging, not a substitute for the NIH/NCCIH baseline.
Scope and Oversight Differences
Physician-led academic programs and NP-led wellness practices operate under different scope-of-practice rules, institutional oversight structures, and credentialing pathways. Colorado grants nurse practitioners substantial independent practice authority, and NP-led care is not inherently inferior. The models are simply structured differently, and patients benefit from knowing which one they are engaging.
Key takeaway: “Integrative medicine” in a clinic’s name describes a care philosophy. It is not a credentialing claim, and practitioner credentials must be verified separately.
Verifying Practitioner Credentials: How to Check Alison Brown’s Board Certification Yourself
Testimonials and marketing language describing a provider as “board-certified” are not verification on their own. Fortunately, licensure is public record.
Using Colorado DORA
Colorado’s Department of Regulatory Agencies (DORA), through its Division of Professions and Occupations, offers a free online license lookup. The process is straightforward:
- Navigate to DORA’s license verification tool.
- Select the nursing profession category.
- Search by the provider’s first and last name.
- Review the results for registered nurse licensure and advanced practice registration.
What a Lookup Typically Reveals
- License type and license number
- Issue and expiration dates
- Current status (active, expired, restricted)
- Advanced practice registration and, where applicable, prescriptive authority
- Any public disciplinary actions
National board certification for nurse practitioners is issued by certifying bodies such as the American Academy of Nurse Practitioners Certification Board or the American Nurses Credentialing Center, both of which offer their own verification tools.
A Repeatable Habit
This step applies to any med-spa, weight-loss, or hormone clinic. Readers should verify the treating provider’s license directly through the relevant state board rather than relying on a clinic website or a review platform.
A Due-Diligence Checklist for Evaluating Vitalogy Health (and Similar Clinics)
- Cross-reference ratings across at least three platforms, weighting sample size before trusting any single average.
- Ask about medication sourcing: FDA-approved brand product or pharmacy-compounded? If compounded, request the name and license of the source facility.
- Verify the treating provider’s license and board certification through the applicable state regulatory board.
- Clarify the cancellation policy in advance, given review complaints about short-notice cancellations.
- Request written pricing and cash-pay or insurance policies before committing, since neither the clinic’s marketing nor third-party directories publish transparent pricing.
- Separate marketing language from credentials. Terms like “integrative medicine” and “whole body approach” describe philosophy; identify whether the provider is an NP, MD, or DO.
Conclusion: What Independent Verification Reveals
The 3.1 to 4.8 rating spread is largely explainable through sample size and platform-specific review mechanics. It does not, by itself, indicate inconsistent care quality.
The 2025 expired-tirzepatide complaint sits within a much larger 2025–2026 regulatory shift affecting compounded GLP-1 providers nationwide. It warrants direct questions about sourcing, but it is not a red flag unique to this practice.
“Integrative medicine” in the clinic’s name reflects a care philosophy and branding choice rather than a credentialing guarantee. NP-led wellness brands differ structurally from NCCIH-aligned, physician-staffed integrative medicine centers, and patients should understand which model they are choosing.
The broader lesson holds for any clinic: informed healthcare decisions require verifying licenses, questioning compounding sources, and reading across multiple review platforms rather than trusting any single data point.
Continue Your Clinic Due-Diligence Research
The verification framework used here (license lookups, regulatory context, and cross-platform review analysis) applies to any weight-loss, hormone, or med-spa clinic a reader may be considering. TopDoctor Magazine’s broader health and wellness coverage offers additional independent reporting to help patients navigate these decisions.
Readers are encouraged to consult primary sources directly, including state nursing and medical boards and FDA compounding updates, rather than relying solely on secondhand summaries, including this one.
Disclosure: This article is an independent editorial analysis. TopDoctor Magazine has no business, advertising, or editorial affiliation with Vitalogy Health and Integrative Medicine.
